Sfoglia per AUTORE
STARZA ID
Collezione AOU Novara
Items : 3
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study. in Haematologica / Haematologica. 2025 Jan 1;110(1):55-67. doi: 10.3324/haematol.2024.285638.
2025
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara
Candoni A; Foa R; Ferrara F; Pizzolo G; Bassan R; Starza ID; Fanin R; Luppi M; Marsili G; Vignetti M; Piciocchi A; Mancini V; De Bellis E; Trastulli F; Ciccone M; De Gobbi M; Cignetti A; Mazzone C; Aprile L; Mauro E; Fanin M; Chiusolo P; Minetto P; Defina M; Delia M; Pasciolla C; Grimaldi F; Cambo B; Santoro L; et alii...
Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study. in Haematologica / Haematologica. 2024 Dec 1;109(12):4095-4099. doi: 10.3324/haematol.2024.285258.
2024
AOU Novara
Di Biase F; Fracchiolla NS; Pierini A; Piccini M; Cardinali V; Salutari P; Lazzarotto D; Giglio F; Mastaglio S; Defina M; Basilico CM; Malfona F; Starza ID; Beldinanzi M; Bellomarino V; Cardinali D; Lunghi M; Kaiser F; Annunziata M; Di Trani M; Foa R; Chiaretti S;
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.
2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara
Foà R; Nanni M; Del Giudice I; Guarini A; Fazi P; Vignetti M; Piciocchi A; Cuneo A; Neri A; De Novi LA; De Propris MS; Pietrasanta D; Mattiello V; Visentin A; Vitale C; Albano F; Molinari MC; Liberati AM; Giordano A; Gottardi D; Galieni P; Patrizi VB; Tani M; Arcari A; Musuraca G; Deodato M; Massaia M; Rigolin GM; Scarfò L; et alii...